Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
47.82
+0.49 (1.04%)
At close: Jul 19, 2024, 4:00 PM
49.56
+1.74 (3.64%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

Ionis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1994
Revenue
776.62787.65587.37810.46729.261,123
Upgrade
Revenue Growth (YoY)
34.84%34.10%-27.53%11.13%-35.04%87.20%
Upgrade
Cost of Revenue
9.949.1314.1210.8411.954.38
Upgrade
Gross Profit
766.68778.51573.25799.61717.321,118
Upgrade
Selling, General & Admin
239.75232.62150.3186.35354.32286.64
Upgrade
Research & Development
916.03899.63833.15643.45535.08465.69
Upgrade
Operating Expenses
1,1561,132983.44829.8889.4752.33
Upgrade
Operating Income
-389.1-353.73-410.19-30.19-172.08365.88
Upgrade
Interest Expense / Income
86.4581.468.129.359.5112.44
Upgrade
Other Expense / Income
-111.79-101.22-160.33-10.39-82.5223.79
Upgrade
Pretax Income
-363.75-333.97-257.99-29.15-99.07329.65
Upgrade
Income Tax
21.0232.3211.74-0.55345.1951.51
Upgrade
Net Income
-384.77-366.29-269.72-28.6-444.26278.14
Upgrade
Net Income Growth
-----1.61%
Upgrade
Shares Outstanding (Basic)
146143142141140140
Upgrade
Shares Outstanding (Diluted)
146143142141140153
Upgrade
Shares Change
1.96%0.95%0.59%1.01%-8.85%14.25%
Upgrade
EPS (Basic)
-2.67-2.56-1.90-0.20-3.182.00
Upgrade
EPS (Diluted)
-2.67-2.56-1.90-0.20-3.181.90
Upgrade
EPS Growth
------8.21%
Upgrade
Free Cash Flow
-341.26-331.3-36.0118.840.77314.72
Upgrade
Free Cash Flow Per Share
-2.35-2.31-0.250.130.012.25
Upgrade
Gross Margin
98.72%98.84%97.60%98.66%98.36%99.61%
Upgrade
Operating Margin
-50.10%-44.91%-69.84%-3.72%-23.60%32.59%
Upgrade
Profit Margin
-49.54%-46.50%-45.92%-3.53%-60.92%24.78%
Upgrade
Free Cash Flow Margin
-43.94%-42.06%-6.13%2.33%0.11%28.04%
Upgrade
Effective Tax Rate
-----15.62%
Upgrade
EBITDA
-254.76-230.01-227.76-0.24-72.4356.17
Upgrade
EBITDA Margin
-32.80%-29.20%-38.78%-0.03%-9.93%31.73%
Upgrade
Depreciation & Amortization
22.5422.522.1119.5617.1614.08
Upgrade
EBIT
-277.31-252.51-249.86-19.8-89.56342.09
Upgrade
EBIT Margin
-35.71%-32.06%-42.54%-2.44%-12.28%30.47%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).